Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

107.49
-0.6850-0.63%
Volume:343.43K
Turnover:36.94M
Market Cap:12.20B
PE:31.78
High:108.25
Open:108.08
Low:106.87
Close:108.17
52wk High:108.49
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.36
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:84.99
PE(LYR):41.99

Loading ...

Market Opportunities Remain Plentiful in Q2, Focus on Tech and HALO Assets

Deep News
·
Apr 16

HALO Asset Revaluation: Oil & Gas ETF ICBC (159017) Focuses on Full Industry Chain

Deep News
·
Apr 16

ALX Oncology names Jeff Knight chief development and operating officer

Reuters
·
Apr 13

KKR Says Uncertainty Is Creating Opportunities In Private Markets

Benzinga_recent_news
·
Apr 10

Long-Term Growth Prospects Emerge for 'HALO' Assets Amid AI Wave

Deep News
·
Apr 09

Neogen names Jennifer Evans Stacey chief legal, compliance officer, board secretary

Reuters
·
Apr 08

Hua An Fund: Banks and HALO Assets Show Resilience, Dividend Strength Stands Out

Deep News
·
Apr 08

Halozyme CEO Helen Torley disposes of common shares worth $633,384

Reuters
·
Apr 08

BRIEF-Halozyme Announces Global Collaboration And License Agreement With Vertex Pharmaceuticals For Hypercon™ Technology

Reuters
·
Apr 07

Halozyme signs exclusive Hypercon licensing deal with Vertex for up to three targets

Reuters
·
Apr 07

Halozyme Therapeutics Inc - Vertex Licenses Halozyme's Hypercon Technology for up to Three Drug Targets

THOMSON REUTERS
·
Apr 07

Halozyme Announces Global Collaboration and License Agreement With Vertex Pharmaceuticals for Hypercon™ Technology

THOMSON REUTERS
·
Apr 07

Zhongtai Securities: HALO Framework Reassesses Value of Scarce Assets, Foresees Commercial Revaluation of Publishing Firms

Stock News
·
Apr 03

Halozyme CEO Helen Torley disposes of USD 2.61 million common shares

Reuters
·
Apr 03

F1 Defies AI Disruption: Liberty Formula One (FWONK.US) Showcases "HALO Premium" Amid Market Turmoil

Stock News
·
Apr 02

Is Halozyme Therapeutics (HALO) Pricing Reflect Its Potential After Recent Share Price Pullback

Simply Wall St.
·
Mar 31

Energy Stocks Outperform Broader Market at Historic Pace, with AI to HALO Fuelling Further Gains

Stock News
·
Mar 31

HALO Assets Remain Vital Infrastructure in AI Era, Not Obsolete, Says Yang Delong

Deep News
·
Mar 28

Investing in Tech Innovation and HALO Assets: Key Strategies for the AI Era

Deep News
·
Mar 25

Geopolitical Catalysts and Rising Risk Aversion Drive Funds Towards HALO Assets as Safe Havens

Deep News
·
Mar 25